MENU
+Compare
ENOV
Stock ticker: NYSE
AS OF
Nov 20, 02:21 PM (EDT)
Price
$27.23
Change
+$0.06 (+0.22%)
Capitalization
1.55B

ENOV Enovis Corp Forecast, Technical & Fundamental Analysis

Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease... Show more

ENOV
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for ENOV with price predictions
Nov 19, 2025

Momentum Indicator for ENOV turns negative, indicating new downward trend

ENOV saw its Momentum Indicator move below the 0 level on November 14, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 79 similar instances where the indicator turned negative. In of the 79 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for ENOV turned negative on October 30, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at .

ENOV moved below its 50-day moving average on November 12, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ENOV crossed bearishly below the 50-day moving average on November 07, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ENOV declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ENOV entered a downward trend on October 23, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ENOV's RSI Oscillator exited the oversold zone, of 44 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where ENOV advanced for three days, in of 281 cases, the price rose further within the following month. The odds of a continued upward trend are .

ENOV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. ENOV’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.769) is normal, around the industry mean (62.926). P/E Ratio (0.000) is within average values for comparable stocks, (35.899). ENOV's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.667). ENOV has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.019). P/S Ratio (0.690) is also within normal values, averaging (84.432).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ENOV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
ENOV
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

ENOV is expected to report earnings to rise 8.37% to 81 cents per share on February 19

Enovis Corp ENOV Stock Earnings Reports
Q4'25
Est.
$0.81
Q3'25
Beat
by $0.10
Q2'25
Beat
by $0.07
Q1'25
Beat
by $0.07
Q4'24
Beat
by $0.07
The last earnings report on November 06 showed earnings per share of 75 cents, beating the estimate of 64 cents. With 128.60K shares outstanding, the current market capitalization sits at 1.55B.
A.I. Advisor
published General Information

General Information

a manufacturer of fluid handling and industrial positioning products

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Industrial Machinery
Address
2711 Centerville Road
Phone
+1 302 252-9160
Employees
6550
Web
https://www.enovis.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MMIZX16.47N/A
N/A
MM S&P 500® Index I
HBLIX14.99N/A
N/A
Hartford Balanced Income I
AWMIX19.79N/A
N/A
CIBC Atlas Mid Cap Equity Institutional
AMCZX17.89N/A
N/A
Alger Mid Cap Growth Z
LOGBX37.54N/A
N/A
Scharf Multi-Asset Opportunity Retail

ENOV and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ENOV has been loosely correlated with CNMD. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if ENOV jumps, then CNMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENOV
1D Price
Change %
ENOV100%
-3.79%
CNMD - ENOV
60%
Loosely correlated
-3.18%
IART - ENOV
57%
Loosely correlated
-2.36%
FELE - ENOV
56%
Loosely correlated
-0.22%
DOV - ENOV
55%
Loosely correlated
-0.08%
PH - ENOV
53%
Loosely correlated
+0.41%
More

Groups containing ENOV

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENOV
1D Price
Change %
ENOV100%
-3.79%
Medical/Nursing Services
industry (216 stocks)
61%
Loosely correlated
-0.68%
Health Services
industry (423 stocks)
-0%
Poorly correlated
-0.04%